← Back to DNA

Ginkgo Bioworks Holdings, Inc. Class A Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 06/05/2025
$20$19$39$39$38$89$56$38
−$47−$83−$81−$60−$91−$56−$217−$166
−$0.75−$1.39−$1.45−$1.10−$1.68−$1.08−$4.23−$3.32
6260565554525150

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.